Cargando…

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children

BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) is the most common bacterial otopathogen associated with otitis media (OM). NTHi persists in biofilms within the middle ears of children with chronic and recurrent OM. Australian Aboriginal children suffer exceptionally high rates of chronic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Sharon L., Seppanen, Elke J., Kirkham, Lea-Ann S., Novotny, Laura A., Bakaletz, Lauren O., Cripps, Allan W., Corscadden, Karli, Coates, Harvey, Vijayasekaran, Shyan, Richmond, Peter C., Thornton, Ruth B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022120/
https://www.ncbi.nlm.nih.gov/pubmed/35463651
http://dx.doi.org/10.3389/fcimb.2022.767083
_version_ 1784690014131585024
author Clark, Sharon L.
Seppanen, Elke J.
Kirkham, Lea-Ann S.
Novotny, Laura A.
Bakaletz, Lauren O.
Cripps, Allan W.
Corscadden, Karli
Coates, Harvey
Vijayasekaran, Shyan
Richmond, Peter C.
Thornton, Ruth B.
author_facet Clark, Sharon L.
Seppanen, Elke J.
Kirkham, Lea-Ann S.
Novotny, Laura A.
Bakaletz, Lauren O.
Cripps, Allan W.
Corscadden, Karli
Coates, Harvey
Vijayasekaran, Shyan
Richmond, Peter C.
Thornton, Ruth B.
author_sort Clark, Sharon L.
collection PubMed
description BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) is the most common bacterial otopathogen associated with otitis media (OM). NTHi persists in biofilms within the middle ears of children with chronic and recurrent OM. Australian Aboriginal children suffer exceptionally high rates of chronic and recurrent OM compared to non-Aboriginal children. NTHi protein vaccines comprised of antigens associated with both adhesion and persistence in a biofilm are under development and could be beneficial for children with chronic and recurrent OM. Understanding the ontogeny of natural antibody development to these antigens provides insight into the value of vaccinating with particular antigens. METHODS: An in-house multiplex fluorescent bead immunoassay was used to measure serum IgG titres and avidity for three putative vaccine antigens: recombinant soluble PilA (rsPilA), ChimV4, and outer membrane protein 26 (OMP26) in sera from Australian Aboriginal otitis-prone children (n=77), non-Aboriginal otitis-prone children (n=70) and non-otitis-prone children (n=36). Serum IgG titres were adjusted for age, and geometric mean concentrations (GMCs) were compared between groups using a univariate analysis model. Antibody avidity was calculated as a relative avidity index and compared between groups using ANOVA. RESULTS: Australian Aboriginal otitis-prone children had lower serum IgG titres to rsPilA and ChimV4 than non-Aboriginal otitis-prone children (p<0.001), and non-otitis-prone children (p<0.020). No differences were observed between serum IgG titres from non-Aboriginal otitis-prone children and non-otitis-prone children. There were also no differences in the proportion of high avidity IgG specific for these antigens between these groups. Serum IgG titres to OMP26 were similar between all groups (p>0.670) although otitis-prone children had a higher proportion of high avidity antibodies to this antigen. CONCLUSIONS: Australian Aboriginal otitis-prone children had lower serum IgG titres to 2/3 major NTHi vaccine candidate antigens, suggesting these children are unable to develop persistent IgG responses due to repeated NTHi exposure. These reduced IgG titres may relate to earlier and more frequent exposure to diverse NTHi strains in Aboriginal children through carriage or infection. These data suggest that Aboriginal children may benefit from immunisation with vaccines containing these antigens to increase titres of protective antibodies.
format Online
Article
Text
id pubmed-9022120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90221202022-04-22 Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children Clark, Sharon L. Seppanen, Elke J. Kirkham, Lea-Ann S. Novotny, Laura A. Bakaletz, Lauren O. Cripps, Allan W. Corscadden, Karli Coates, Harvey Vijayasekaran, Shyan Richmond, Peter C. Thornton, Ruth B. Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) is the most common bacterial otopathogen associated with otitis media (OM). NTHi persists in biofilms within the middle ears of children with chronic and recurrent OM. Australian Aboriginal children suffer exceptionally high rates of chronic and recurrent OM compared to non-Aboriginal children. NTHi protein vaccines comprised of antigens associated with both adhesion and persistence in a biofilm are under development and could be beneficial for children with chronic and recurrent OM. Understanding the ontogeny of natural antibody development to these antigens provides insight into the value of vaccinating with particular antigens. METHODS: An in-house multiplex fluorescent bead immunoassay was used to measure serum IgG titres and avidity for three putative vaccine antigens: recombinant soluble PilA (rsPilA), ChimV4, and outer membrane protein 26 (OMP26) in sera from Australian Aboriginal otitis-prone children (n=77), non-Aboriginal otitis-prone children (n=70) and non-otitis-prone children (n=36). Serum IgG titres were adjusted for age, and geometric mean concentrations (GMCs) were compared between groups using a univariate analysis model. Antibody avidity was calculated as a relative avidity index and compared between groups using ANOVA. RESULTS: Australian Aboriginal otitis-prone children had lower serum IgG titres to rsPilA and ChimV4 than non-Aboriginal otitis-prone children (p<0.001), and non-otitis-prone children (p<0.020). No differences were observed between serum IgG titres from non-Aboriginal otitis-prone children and non-otitis-prone children. There were also no differences in the proportion of high avidity IgG specific for these antigens between these groups. Serum IgG titres to OMP26 were similar between all groups (p>0.670) although otitis-prone children had a higher proportion of high avidity antibodies to this antigen. CONCLUSIONS: Australian Aboriginal otitis-prone children had lower serum IgG titres to 2/3 major NTHi vaccine candidate antigens, suggesting these children are unable to develop persistent IgG responses due to repeated NTHi exposure. These reduced IgG titres may relate to earlier and more frequent exposure to diverse NTHi strains in Aboriginal children through carriage or infection. These data suggest that Aboriginal children may benefit from immunisation with vaccines containing these antigens to increase titres of protective antibodies. Frontiers Media S.A. 2022-04-07 /pmc/articles/PMC9022120/ /pubmed/35463651 http://dx.doi.org/10.3389/fcimb.2022.767083 Text en Copyright © 2022 Clark, Seppanen, Kirkham, Novotny, Bakaletz, Cripps, Corscadden, Coates, Vijayasekaran, Richmond and Thornton https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Clark, Sharon L.
Seppanen, Elke J.
Kirkham, Lea-Ann S.
Novotny, Laura A.
Bakaletz, Lauren O.
Cripps, Allan W.
Corscadden, Karli
Coates, Harvey
Vijayasekaran, Shyan
Richmond, Peter C.
Thornton, Ruth B.
Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title_full Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title_fullStr Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title_full_unstemmed Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title_short Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
title_sort australian aboriginal otitis-prone children produce high-quality serum igg to putative nontypeable haemophilus influenzae vaccine antigens at lower titres compared to non-aboriginal children
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022120/
https://www.ncbi.nlm.nih.gov/pubmed/35463651
http://dx.doi.org/10.3389/fcimb.2022.767083
work_keys_str_mv AT clarksharonl australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT seppanenelkej australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT kirkhamleaanns australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT novotnylauraa australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT bakaletzlaureno australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT crippsallanw australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT corscaddenkarli australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT coatesharvey australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT vijayasekaranshyan australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT richmondpeterc australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren
AT thorntonruthb australianaboriginalotitispronechildrenproducehighqualityserumiggtoputativenontypeablehaemophilusinfluenzaevaccineantigensatlowertitrescomparedtononaboriginalchildren